Diabetes mellitus leads to disturbances in lipoprotein homeostasis par
ticularly when there is poor glycaemic control. The resulting abnormal
ities in concentration and composition of the circulating lipoproteins
are modified by inherited variation in the genes coding for apolipopr
oteins, for the lipoprotein-processing enzymes, and possibly for lipop
rotein receptors. Thus, poorly controlled diabetes provides an opportu
nity to observe the phenotypic effects of recessive mutant alleles tha
t would otherwise be silent. This phenomenon should be considered when
one attempts to understand the pathogenesis of variant phenotypes, on
es differing from those typical of diabetes mellitus alone. Our unders
tanding of how genetic variation modulates the expression of hyperlipi
daemia in diabetes is still rudimentary-it now seems probable that man
y other genetic conditions affecting lipoprotein metabolism in diabete
s will eventually be brought to light.